These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 9280118)
1. Single-organism model of host defense against infection: a novel immunotoxicologic approach to evaluate immunomodulatory drugs. Herzyk DJ; Ruggieri EV; Cunningham L; Polsky R; Herold C; Klinkner AM; Badger A; Kerns WD; Bugelski PJ Toxicol Pathol; 1997; 25(4):351-62. PubMed ID: 9280118 [TBL] [Abstract][Full Text] [Related]
2. Liquiritigenin, a licorice flavonoid, helps mice resist disseminated candidiasis due to Candida albicans by Th1 immune response, whereas liquiritin, its glycoside form, does not. Lee JY; Lee JH; Park JH; Kim SY; Choi JY; Lee SH; Kim YS; Kang SS; Jang EC; Han Y Int Immunopharmacol; 2009 May; 9(5):632-8. PubMed ID: 19264152 [TBL] [Abstract][Full Text] [Related]
3. Effect of nucleotide restriction and supplementation on resistance to experimental murine candidiasis. Fanslow WC; Kulkarni AD; Van Buren CT; Rudolph FB JPEN J Parenter Enteral Nutr; 1988; 12(1):49-52. PubMed ID: 3278158 [TBL] [Abstract][Full Text] [Related]
4. In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon. Garner RE; Kuruganti U; Czarniecki CW; Chiu HH; Domer JE Infect Immun; 1989 Jun; 57(6):1800-8. PubMed ID: 2498208 [TBL] [Abstract][Full Text] [Related]
5. Correlation between in vivo and in vitro studies of modulation of resistance to experimental Candida albicans infection by cyclophosphamide in mice. Bistoni F; Baccarini M; Blasi E; Marconi P; Puccetti P; Garaci E Infect Immun; 1983 Apr; 40(1):46-55. PubMed ID: 6339410 [TBL] [Abstract][Full Text] [Related]
6. Immunomodulation by the new synthetic thiazole derivative tiprotimod. 3rd communication: influence on host resistance to microorganisms, tumors and on experimental immune disorders. Schorlemmer HU; Dickneite G; Hänel H; Dürckheimer W; Sedlacek HH Arzneimittelforschung; 1989 Oct; 39(10):1235-9. PubMed ID: 2692570 [TBL] [Abstract][Full Text] [Related]
7. Active and passive immunization against oral Candida albicans infection in a murine model. Farah CS; Ashman RB Oral Microbiol Immunol; 2005 Dec; 20(6):376-81. PubMed ID: 16238599 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of an extract of North American ginseng (Panax quinquefolius L.) in Candida albicans-infected complement-deficient mice. Trammell RA; Cox L; Pikora J; Murphy LL; Toth LA J Ethnopharmacol; 2012 Jan; 139(2):414-21. PubMed ID: 22138349 [TBL] [Abstract][Full Text] [Related]
9. Protection of C3H/HE J mice from development of Candida albicans infection by oral administration of Juzen-taiho-to and its component, Ginseng radix: possible roles of macrophages in the host defense mechanisms. Akagawa G; Abe S; Tansho S; Uchida K; Yamaguchi H Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):73-89. PubMed ID: 8683040 [TBL] [Abstract][Full Text] [Related]
10. Host defence against disseminated Candida albicans infection and implications for antifungal immunotherapy. Vonk AG; Netea MG; van der Meer JW; Kullberg BJ Expert Opin Biol Ther; 2006 Sep; 6(9):891-903. PubMed ID: 16918256 [TBL] [Abstract][Full Text] [Related]
11. Induction of protective Th1 responses to Candida albicans by antifungal therapy alone or in combination with an interleukin-4 antagonist. Cenci E; Mencacci A; Del Sero G; Fé d'Ostiani C; Montagnoli C; Bacci A; Bistoni F; Romani L J Chemother; 1998 Apr; 10(2):160-3. PubMed ID: 9603646 [No Abstract] [Full Text] [Related]
12. Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice. Brieland J; Essig D; Jackson C; Frank D; Loebenberg D; Menzel F; Arnold B; DiDomenico B; Hare R Infect Immun; 2001 Aug; 69(8):5046-55. PubMed ID: 11447185 [TBL] [Abstract][Full Text] [Related]
13. Studies on defense mechanisms against Candida albicans infection in congenitally athymic nude (nu/nu) mice. Tabeta H; Mikami Y; Abe F; Ommura Y; Arai T Mycopathologia; 1984 Feb; 84(2-3):107-13. PubMed ID: 6717553 [TBL] [Abstract][Full Text] [Related]
17. Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis. Vonk AG; Netea MG; van Krieken JH; Iwakura Y; van der Meer JW; Kullberg BJ J Infect Dis; 2006 May; 193(10):1419-26. PubMed ID: 16619190 [TBL] [Abstract][Full Text] [Related]
18. Platelet-activating factor-induced early activation of NF-kappa B plays a crucial role for organ clearance of Candida albicans. Choi JH; Ko HM; Kim JW; Lee HK; Han SS; Chun SB; Im SY J Immunol; 2001 Apr; 166(8):5139-44. PubMed ID: 11290796 [TBL] [Abstract][Full Text] [Related]
19. Bone marrow colony-formation in vitro after infection of genetically defined inbred mice with Candida albicans. Wanasaengsakul S; Ashman RB Microb Pathog; 2004 Apr; 36(4):211-7. PubMed ID: 15001227 [TBL] [Abstract][Full Text] [Related]
20. Influence of leflunomide on gastrointestinal Candida albicans infection induced in naive and arthritic newborn mice. Dimitrova P; Ivanovska N Int Immunopharmacol; 2006 Nov; 6(11):1682-9. PubMed ID: 16979122 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]